+499.5%
MRNA vs CG
-24.3%
+523.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -1.0% |
| 7D | +5.5% | -4.3% | +9.8% | +8.6% |
| 30D | +158.7% | -5.1% | +163.8% | +170.0% |
| 3M | +182.1% | +8.7% | +173.5% | +174.8% |
| 6M | +151.8% | -9.2% | +161.0% | +169.3% |
| YTD | +393.6% | -18.9% | +412.4% | +452.4% |
| 1Y | +499.5% | -25.6% | +525.1% | +550.9% |
| All | +499.5% | -24.3% | +523.7% | +550.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CG.
Daily Out/Under-Performance
Portfolio return minus CG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling